Scientific Advisory Committee

Anthony Cerami, PhDAnthony Cerami, PhD
Dr. Cerami has had a successful career applying detailed biochemical insights into understanding the pathogenesis of disease, and translating these discoveries into novel therapeutic products which have wide clinical utility.

He received his PhD from the Rockefeller University and completed a postdoctoral fellowship at Harvard Medical School, and has received three honorary Doctorates. Dr. Cerami was the Dean of Graduate and Post Graduate Studies at Rockefeller University. He established what is now the Feinstein Institute for Medical Research.

Dr. Cerami has been the inventor or co-inventor of over 150 issued U.S. patents and hundreds of foreign counterparts, including the anti-TNF monoclonal antibody that has been approved by the FDA for the treatment of Chron’s disease and Rheumatoid arthritis. Dr. Cerami is also the inventor of the hemoglobin A1c test that is used by diabetics worldwide. He is the author or co-author of over 500 scientific publications.

Chris-Czura-Feinstein-PressChristopher J Czura, PhD
Dr. Czura is vice president of the Feinstein Institute for Medical Research, executive publisher of the Feinstein Institute Press’ international, peer-reviewed journals Molecular Medicine and Bioelectronic Medicine, executive producer of the Merinoff Conference Series, and chief financial officer for the Elmezzi Graduate School of Molecular Medicine. Dr. Czura provides oversight of the Institute’s daily operations and $95 million annual budget.  He collaborates with the president of the Institute to develop and execute strategic plans, and is committed to building successful programs that nurture the collaborative and interactive environment of the Feinstein Institute. He leads project teams in the design and oversight of construction of new laboratory facilities and renovation projects.

A molecular biologist by training, Dr. Czura’s research interests focus on autonomic neural regulation of hemostasis and inflammation.  He received his B.S. in biotechnology from William Paterson University in 1996 and a doctoral degree in molecular microbiology from Stony Brook University in 2009.  He is author or co-author of approximately 80 peer-reviewed publications, book chapters and meeting abstracts, and co-inventor on a patent that describes vagus nerve stimulation to control hemorrhage.

Betty Diamond, MDBetty Diamond, MD
Dr. Diamond graduated with a BA from Harvard University and an MD from Harvard Medical School. She performed a residency in internal medicine at Columbia Presbyterian Medical Center and received postdoctoral training in immunology at the Albert Einstein College of Medicine.

Dr. Diamond has headed the rheumatology divisions at Albert Einstein School of Medicine and at Columbia University Medical Center. She also directed the Medical Scientist Training Program at Albert Einstein School of Medicine for many years. She is currently head of the Center for Autoimmune and Musculoskeletal Diseases at The Feinstein Institute for Medical Research and director of the PhD and MD/PhD programs at the Hofstra Northwell School of Medicine.

A former president of the American Association of Immunology, Dr. Diamond has also served on the board of directors of the American College of Rheumatology and the Scientific Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Dr. Diamond is a fellow of the American Association for the Advancement of Science (AAAS) and a member of the Institute of Medicine.

Kevin J Tracey, MD Kevin J Tracey, MD
Dr. Tracey is president of The Feinstein Institute for Medical Research, and professor of Molecular Medicine and Neurosurgery at the Hofstra Northwell School of Medicine. He is a leader in the study of the molecular basis of inflammation. He and his colleagues identified the neural mechanism for controlling the immunological responses to infection and injury, and developed devices to replace anti-inflammatory drugs in clinical trials of rheumatoid arthritis, a new field termed bioelectronic medicine. The recipient of numerous awards and honors, including an honorary degree from the Karolinska Institute, Dr. Tracey is a fellow in the American Association for the Advancement of Science, and a member in the American Society for Clinical Investigation, and the Association of American Physicians. He is co-founder and Councilor of the Global Sepsis Alliance.

Professor Tracey graduated summa cum laude from Boston College, majoring in chemistry, and received his MD from Boston University. He trained in neurosurgery at the New York Hospital/Cornell University Medical Center, and was guest investigator at The Rockefeller University. Since 1992 he has directed the Laboratory of Biomedical Science in Manhasset, NY, where in 2005 he was appointed president of the Feinstein Institute. Dr. Tracey delivers lectures nationally and internationally on inflammation, sepsis, the neuroscience of immunity, and bioelectronic medicine. He is the author of Fatal Sequence (Dana Press) and more than 320 scientific papers.